We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Conventional and High-Dose Radiation in Treating Early Prostate Cancer—Reply

James A. Talcott, MD, SM; Anthony L. Zietman, MD
JAMA. 2010;304(2):155-156. doi:10.1001/jama.2010.928.
Text Size: A A A
Published online


In Reply: As Dr Vikram notes, the 9-Gy–higher radiation dose in PROG 9509 has not produced a survival benefit despite halving biochemical, or prostate-specific antigen, progression.1,2 Given the association between progression-free survival and overall survival, an overall survival benefit from the higher dose may emerge. However, such an advantage will be delayed by the relatively indolent natural history of prostate cancer and attenuated by competing mortality, given the 76-year median age of surveyed men. Both effects were seen in the Scandinavian randomized trial of surgery vs observation for early prostate cancer.3 We do believe that finding no outcome differences between study groups using a sensitive, treatment-specific survey instrument is stronger evidence of similar long-term outcomes than the comment that patients “stopped complaining” suggests.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




July 14, 2010
Bhadrasain Vikram, MD
JAMA. 2010;304(2):155-156. doi:10.1001/jama.2010.927.
July 14, 2010
Boris Pasche, MD, PhD; Robert A. McNutt, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2010;304(2):155-156. doi:10.1001/jama.2010.929.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.